Skip to main content
Log in

Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Low chloropromazine (CPZ) levels have been measured in chronically treated schizophrenics. We tested six such patients to determine whether a 2-week CPZ-free period (drug holiday) would improve plasma CPZ levels. We also monitored psychiatric symptoms, autonomic function, and extrapyramidal signs. We found these patients to have low predose CPZ levels that did not change appreciably after the drug holiday. Peak levels following the holiday averaged 28 ±7 ng/ml higher than those measured prior to the holiday. Drug holidays are safe and should be examined more thoroughly as a means of improving plasma neuroleptic levels in chronically treated schizophrenics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Brooks GW (1959) Withdrawal from neuroleptic drugs. Am J Psychiatry 115:931–932

    Google Scholar 

  • Committee on Nomenclature and Statistics of the American Psychiatric Association (1968) Diagnostic and statistical manual of mental disorders. II

  • Curry SH (1968) Determination of nanogram quantities of chloropromazine and some of its metabolites in plasma, using gas-liquid cromatography with an electron capture detector. Anal Chem 40:1251–1255

    Google Scholar 

  • Curry SH, Marshall JH, Davies JM, Janowsky DS (1970) Chlorpromazine plasma levels and effects. Arch Gen Psychiatry 22:289–296

    Google Scholar 

  • Dahl SG, Strandjord RE (1977) Pharmacokinetics of chlorpromazine after single and chronic dosage. Clin Pharmacol Ther 21:327–448

    Google Scholar 

  • Denber H, Bird EG (1955) Chlorpromazine in the treatment of mental illness. Side effects and relapse rates. Am J Psychiatry 112:465–468

    Google Scholar 

  • Gardos G, Cole JO, Tarsy D (1978) Withdrawal syndromes associated with antipsychotic drugs. Am J Psychiatry 135:1321–1324

    Google Scholar 

  • Hershon HI, Kennedy PF, McGuire RJ (1972) Persistence of extrapyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy. Br J Psychiatry 120:41–50

    Google Scholar 

  • Jacobs JW, Bernhard MR, Delgado A, Strain JJ (1977) Screening for organic mental syndromes in the medically ill. Ann Intern Med 86:40–46

    Google Scholar 

  • Lacoursiere RB, Spon HE, Thompson K (1976) Medical effects of abrupt neuroleptic withdrawal. Comp Psychiatry 17:285–294

    Google Scholar 

  • Overall JE, Hollister LE, Pichot P (1967) Major psychiatric disorders. Arch Gen Psychiatry 16:146–151

    Google Scholar 

  • Phillipson OT, McKeown JM, Baker J, Healey AF (1977) Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis. Br J Psychiatry 131:172–184

    Google Scholar 

  • Prien RI, Cole JO, Belkin NT (1968) Relapse in chronic schizophrenics following abrupt withdrawal of tranquilizing medication. Br. J Psychiatry 115:679–686

    Google Scholar 

  • Rivera-Calimlim L, Casaneda L, Lasagna L (1973) Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clin Pharmacol Ther 14:978–986

    Google Scholar 

  • Rivera-Calimlim L, Gift T, Nasrallah HA, Wyatt RJ, Lasagna (1978) Low plasma levels of CPZ in patients chronically treated with neuroleptics. Commun Psychopharmacol 2:113–121

    Google Scholar 

  • Rivera-Calimlim L, Nasrallah HA, Strauss J, Lasagna L (1976) Clinical response and plasma levels. Am J Psychiatry 133:646–652

    Google Scholar 

  • Sakalis G, Curry SH, Mould GP, Lader MH (1972) Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther 13:931–946

    Google Scholar 

  • Smith RC, Crayton J, Dekirmenjian H, Klass D, Davis JM (1979) Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients. Arch Gen Psychiatry 36:579–584

    Google Scholar 

  • Wode-Helgodt G, Borg S, Tyro B, Sedvall G (1978) Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Acta Psychiatr Scand 58:149–173

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hershey, L.A., Gift, T., Atkins, R.W. et al. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients. Psychopharmacology 73, 355–358 (1981). https://doi.org/10.1007/BF00426465

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00426465

Key words

Navigation